International Business Machines Corporation, commonly known as IBM or "Big Blue," is a global technology and consulting enterprise headquartered in Armonk, New York. Founded in 1911, the company provides a broad portfolio of enterprise software, IT infrastructure, hybrid cloud solutions, and business consulting services to large corporations and governments worldwide. IBM's key growth engines include its Red Hat open-source hybrid cloud platform, the Watsonx AI and data platform, and its expanding generative AI consulting practice. The company also remains a dominant player in the mainframe computing market, with its Z series systems processing mission-critical transactions for major banks, airlines, and insurers. Investors follow IBM for its enterprise AI strategy, recurring software revenue growth, robust free cash flow generation, and a dividend that has increased for 31 consecutive years. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the last 30 calendar days, IBM shares declined roughly 22%, falling from a closing price of $289.52 on July 2, 2026, to approximately $225.84 as of August 3, 2026. The overwhelming majority of that decline occurred on a single day — July 14 — when the stock plummeted 25.2% after IBM unexpectedly released preliminary second-quarter results that fell short of Wall Street estimates. Since that collapse, the stock has stabilized in the $205-$228 range, with some modest recovery in late July following the official Q2 earnings report.
Zooming out to the full quarter, the picture is similarly stark. IBM began the second quarter near multi-year highs, buoyed by a strong Q1 2026 in which revenue grew 9% year over year and infrastructure revenue jumped 15% on the rollout of the new z17 mainframe. By mid-July, however, those gains had evaporated. The quarterly peak of $306.13 on July 7 gave way to a low of $199.19 on July 23, marking a peak-to-trough decline of roughly 35%. The stock has since partially recovered but remains down significantly for the quarter and is now down approximately 26% year-to-date.
The dominant catalyst was IBM's surprise preliminary Q2 earnings release on July 14, which shocked markets and triggered the largest single-day percentage decline in the company's modern trading history. IBM reported preliminary Q2 revenue of $17.2 billion — just 1% higher than a year earlier — well below the $17.86 billion consensus estimate. Adjusted earnings per share of $2.93 also missed the $3.02 analysts had expected.
In a letter to shareholders, CEO Arvind Krishna explained that during the final weeks of June, enterprise clients dramatically shifted their quarterly capital expenditure budgets toward servers, storage, and memory purchases in an effort to secure supply-constrained AI infrastructure ahead of anticipated price increases. "While we anticipated some supply chain-related impact in our expectations, we did not anticipate the magnitude of the capex reprioritization," Krishna wrote, adding with unusual candor: "This quarter we faltered. We did not adapt and move quickly enough, and numerous large deals failed to close on the timelines we expected."
The impact was concentrated in IBM's infrastructure segment, where revenue fell 7%, with Z mainframe revenue slumping 42%. Software revenue grew 5% but also missed estimates, while consulting revenue was flat. The warning reverberated across the broader enterprise software sector, dragging down shares of NOW, CRM, ACN, and even MSFT in sympathy trading, while AI hardware and cybersecurity names rallied. HSBC downgraded IBM to Reduce with a $191 price target, though Oppenheimer and Morgan Stanley raised their targets, reflecting a deep split in analyst sentiment.
When IBM released its full Q2 results on July 22, management confirmed the preliminary figures and lowered full-year 2026 constant-currency revenue growth guidance to 4%-5%, down from the prior "more than 5%." CFO James Kavanaugh told Reuters that the mainframe stack alone impacted IBM's growth by over five percentage points in the quarter. Shares rose modestly in extended trading on July 22 as executives sought to reassure investors that the spending shift represented delayed deal timing rather than permanent structural displacement.
The broader quarterly narrative reflects a sharp reversal of fortune. IBM entered the second quarter with considerable momentum: Q1 2026 revenue had grown 9%, the z17 mainframe launch was tracking toward what management called the strongest start in the program's history, and the stock had returned 139% over the prior three years — nearly double the S&P 500's gain. The company had guided for full-year constant-currency revenue growth above 5%, underpinned by accelerating software growth of 10% or more.
That narrative unraveled in a matter of days. The underlying issue — enterprise customers redirecting IT budgets toward AI hardware infrastructure — had been building throughout the quarter as memory shortages intensified and hardware prices climbed. Memory chipmakers such as MU and SNDK reported data center revenue surging by triple-digit percentages, signaling that corporate AI infrastructure spending was crowding out traditional software and mainframe budgets. IBM's own distributed infrastructure business, which includes Power servers and storage, grew 37% in the quarter — confirming that even within IBM, the money was shifting toward hardware. The quarter ultimately exposed IBM's vulnerability to spending pattern disruptions in ways that its own management had underestimated. From what I see, this highlights the need to monitor capex shifts closely in the months ahead.
The critical question for IBM investors is whether the Q2 shortfall represents a temporary timing issue or signals a longer-term challenge to the company's software-centric growth strategy. Key factors to monitor include whether the large deals that slipped in Q2 close in the second half of 2026, validating management's assertion that demand was delayed rather than lost. Red Hat's revenue trajectory — up 11% in Q2 — remains a vital indicator of IBM's hybrid cloud competitiveness, while the $5 billion Lightwell cybersecurity initiative and the company's $10 billion-plus quantum computing investment program represent significant long-term bets. Macroeconomic conditions, including memory chip supply constraints and enterprise AI hardware spending patterns, will continue to influence IBM's near-term performance. Additionally, the company's free cash flow generation and dividend sustainability will remain central to the investment thesis for income-oriented shareholders. IBM's forward price-to-earnings multiple has compressed to roughly 17x following the selloff, a level that may attract value-conscious investors if earnings stabilize in subsequent quarters. I’m watching this closely as earnings reports come in.
In volatile market environments like the one currently facing IBM, I often turn to data-driven tools to navigate rapid sentiment shifts. Tickeron’s Trending AI Robots page curates a selection of top-performing AI-powered trading bots from a broader universe of hundreds of bots actively trading thousands of tickers. Only the most relevant and consistently high-performing bots appear in this curated section, each employing distinct strategies, timeframes, and performance metrics tailored to different market conditions. These algorithmic systems analyze vast quantities of market data in real time, offering traders an alternative to purely discretionary decision-making during periods of heightened uncertainty. Exploring the Trending AI Robots page can provide traders with insight into how automated strategies are positioning themselves across equities, including technology sector names experiencing significant price dislocation.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The RSI Indicator for IBM moved out of oversold territory on July 24, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In of the 28 cases the stock moved higher. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on July 28, 2026. You may want to consider a long position or call options on IBM as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for IBM just turned positive on July 31, 2026. Looking at past instances where IBM's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IBM advanced for three days, in of 372 cases, the price rose further within the following month. The odds of a continued upward trend are .
IBM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
IBM moved below its 50-day moving average on July 14, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for IBM crossed bearishly below the 50-day moving average on July 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.116) is normal, around the industry mean (7.513). P/E Ratio (19.862) is within average values for comparable stocks, (70.235). IBM's Projected Growth (PEG Ratio) (2.269) is slightly higher than the industry average of (1.072). Dividend Yield (0.030) settles around the average of (0.026) among similar stocks. P/S Ratio (3.081) is also within normal values, averaging (147.213).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IBM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of various computer products through the use of advanced information technology
Industry InformationTechnologyServices